Large vessel involvement in biopsy-proven giant cell arteritis: incidence, distribution, and predictors

Scandinavian Journal of Rheumatology

Volumn 46, Issue 3, 2017, Pages 215-221

  Naderi, N ^a   Mohammad, A J ^b,c,d   Turesson, C ^b,d  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL AORTA; ABDOMINAL ECTASIA; ADULT; AGED; AORTA ECTASIA; AORTIC DISEASE; AORTIC DISSECTION; ARTERY DISEASE; ARTICLE; ASCENDING AORTA; BLOOD VESSEL BIOPSY; BRAIN ARTERY ANEURYSM; CAROTID ARTERY DISEASE; CELIAC ARTERY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DESCENDING AORTA; FEMALE; FEMORAL ARTERY; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; ILIAC ARTERY; INCIDENCE; KIDNEY ARTERY; LARGE VESSEL INVOLVEMENT; LOWER LIMB; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SUBCLAVIAN ARTERY; SUPERIOR MESENTERIC ARTERY; THORACIC AORTA ANEURYSM; VASCULAR DISEASE; ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTIC ANEURYSM, THORACIC; AORTIC DISEASES; BIOPSY; DILATATION, PATHOLOGIC; GIANT CELL; MIDDLE AGED; PATHOLOGY; POLYMYALGIA RHEUMATICA; SWEDEN; TEMPORAL ARTERY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTIC ANEURYSM, THORACIC; AORTIC DISEASES; BIOPSY; DILATATION, PATHOLOGIC; FEMALE; GIANT CELL ARTERITIS; GIANT CELLS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; SWEDEN; TEMPORAL ARTERIES;

EID: 84979085509     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009742.2016.1190984     Document Type: Article

References (38)

1. Hutchinson J., Diseases of the arteries. Arch Surg Lond 1889;90:323.
2. Mohammad AJ, Nilsson J-Å, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis 2015;74:993–7.
3. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993;41:1187–92.
4. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981;24:1414–18.
5. Ninet JP, Bachet P, Dumontet CM, Du Colombier PB, Stewart MD, Pasquier JH. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med 1990;88:13–20.
6. Fauchald P, Rygvold O, Øystese B. Temporal arteritis and polymyalgia rheumatica:clinical and biopsy findings. Ann Intern Med 1972;77:845–52.
7. Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl 1972;533:1–131.
8. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999;38:444–7.
9. Blockmans D, Ceuninck LD, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica:a prospective study in 35 patients. Rheumatology (Oxford) 2007;46:672–7.
10. Agard C, Barrier J-H, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis:A case–control prospective study using helical aortic computed tomodensitometric scan. Arthritis Care Res 2008;59:670–6.
11. Prieto-González S, Arguis P, García-Martínez A, Espígol-Frigolé G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis:prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71:1170–6.
12. Barrier J, Piedbois P, Ponge T, Taopignong A, Peltier P, Planchon B, et al. [Frequency and course of large arterial vessel involvement in Horton's disease. The importance of doppler investigation], in French. Bulletin de la Société Nationale Française de Médecine Interne. 1984;6 (poster no. 20).
13. Blockmans D, Ceuninck LD, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis:A prospective study of 35 patients. Arthritis Care Res 2006;55:131–7.
14. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis:a population-based study over 50 years. Arthritis Rheum 2003;48:3522–31.
15. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995;122:502–7.
16. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain:a population-based study. Medicine (Baltimore) 2004;83:335–41.
17. García-Martínez A, Hernández-Rodríguez J, Arguis P, Paredes P, Segarra M, Lozano E, et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis:A cross-sectional screening of fifty-four prospectively followed patients. Arthritis Care Res 2008;59:422–30.
18. Souza, AW, Okamoto, KY, Abrantes F, Schau B, Bacchiega, AB, Shinjo, SK. Giant cell arteritis:a multicenter observational study in Brazil. Clinics (Sao Paulo) 2013;68:317–22.
19. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–8.
20. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975;83:806–12.
21. Czihal M, Zanker S, Rademacher A, Tatò F, Kuhlencordt P, Schulze-Koops H, et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol 2012;41:231–6.
22. Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006;113:1842–5.
23. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis:clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996;35:1161–8.
24. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012;41:866–71.
25. Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, et al. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 2000;19:73–5.
26. Von Blotzheim SG, Borruat FX. [Neuro-ophthalmological complications of Horton’s disease], in French. Rev Med Suisse Romande 1996;116:21–5.
27. Rojo-Leyva F, Ratliff NB, Cosgrove DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000;43:901–7.
28. Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis 2015;74:129–35.
29. Brack A, 0Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311–17.
30. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008;47:96–101.
31. Aschwanden M, Kesten F, Stern M, Thalhammer C, Walker UA, Tyndall A, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010;69:1356–9.
32. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505–15.
33. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 2008;20:131–7.
34. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis:from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129–38.
35. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992;130:10–16.
36. Kawakami M, Cerami A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981;154:631–9.
37. Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis:a cohort study. Ann Intern Med 2014;160:73–80.
38. Amiri N, De Vera M, Choi HK, Sayre EC, Avina-Zubieta JA. Increased risk of cardiovascular disease in giant cell arteritis:a general population-based study. Rheumatology (Oxford) 2016;55:33–40.